This medication is taken by injection.
Extavia® and Betaseron® are brand names for interferon beta 1b, a medication manufactured by a biotechnological process from one of the naturally occurring interferons (a type of protein).
Betaseron and Extavia are approved by the U.S. Food and Drug Administration (FDA) for the treatment of relapsing forms of multiple sclerosis to include clinically isolated syndrome, relapsing remitting disease, and active secondary progressive disease, in adults.
Click here to read the Extavia Prescribing Information for healthcare professionals.
Click here to read the Extavia Medication Guide for patients.
Click here to read the Betaseron Prescribing Information for healthcare professionals.
Click here to read the Betaseron Medication Guide for patients.
Extavia Go Program
Financial Assistance Program
EXTAVIA GO PROGRAM